gabapentin has been researched along with apnea in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hauer, J; Mackey, D | 1 |
| Barkats, M; Bartoli, M; Borges-Correia, A; Ehinger, Y; Matagne, V; Roux, JC; Saidi, L; Villard, L | 1 |
2 other study(ies) available for gabapentin and apnea
| Article | Year |
|---|---|
Treatment with gabapentin associated with resolution of apnea in two infants with neurologic impairment.
Topics: Amines; Analgesics; Apnea; Central Nervous System; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Infant; Muscle Hypertonia; Pain; Treatment Outcome | 2013 |
A codon-optimized Mecp2 transgene corrects breathing deficits and improves survival in a mouse model of Rett syndrome.
Topics: Amines; Animals; Apnea; Codon; Cyclohexanecarboxylic Acids; Dependovirus; Disease Models, Animal; Disease Progression; Gabapentin; gamma-Aminobutyric Acid; Genetic Therapy; Genetic Vectors; Green Fluorescent Proteins; Male; Mesencephalon; Methyl-CpG-Binding Protein 2; Mice, Inbred C57BL; Mice, Knockout; Respiration; Rett Syndrome; Survival Analysis; Tyrosine 3-Monooxygenase; Weight Gain | 2017 |